bluebird bio Inc
(NAS:BLUE)
$
0.4171
0.0121 (2.99%)
Market Cap: 81.10 Mil
Enterprise Value: 376.50 Mil
PE Ratio: 0
PB Ratio: 0
GF Score: 31/100 bluebird bio Inc at Jefferies Healthcare Conference (Virtual) Transcript
Jun 04, 2020 / 07:30PM GMT
Release Date Price:
$43.31
(+2.76%)
Biren N. Amin
Jefferies LLC, Research Division - MD and Senior Equity Research Analyst
Good afternoon, everyone. This is Biren Amin. I want to welcome everyone to the Jefferies Healthcare Conference. I would like to introduce our next company, bluebird bio. This is a fireside chat format with Nick Leschly, bluebird's CEO; Dave Davidson, bluebird's Chief Medical Officer; and Chip Baird, bluebird's Chief Financial Officer. If anyone in the audience would like to ask questions, they can e-mail me at [email protected].
So welcome, bluebird team. It's great to have you on.
Questions & Answers
Biren N. Amin
Jefferies LLC, Research Division - MD and Senior Equity Research Analyst
Maybe we could get started with, a few weeks ago, you unveiled a cost-saving strategy. Can we maybe, I guess, start with what drove that and whether you feel you've optimized your operating plan with the announcement of that strategy?
Nick Leschly
bluebird bio, Inc. - President, CEO & Director
Yes. This is Nick Leschly
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot